BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37291380)

  • 1. Flow Cytometry of CD5-Positive Hairy Cell Leukemia.
    Cenariu D; Rus I; Bergthorsson JT; Grewal R; Cenariu M; Greiff V; Tigu AB; Dima D; Selicean C; Petrushev B; Zdrenghea M; Fromm J; Aanei CM; Tomuleasa C
    Mol Diagn Ther; 2023 Sep; 27(5):593-599. PubMed ID: 37291380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
    Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
    Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of hairy cell leukemia by flow cytometry.
    Stetler-Stevenson M; Tembhare PR
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():11-3. PubMed ID: 21504292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
    Mason EF; Pozdnyakova O; Li B; Dudley G; Dorfman DM
    Am J Clin Pathol; 2017 Jul; 148(1):33-41. PubMed ID: 28575142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
    Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
    Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of interleukin-6 in a patient with polyclonal hairy B-cell lymphoproliferative disorder: a case report.
    Okamoto A; Inaba T; Fujita N
    Lab Hematol; 2007; 13(4):124-7. PubMed ID: 18192143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.
    Venkataraman G; Aguhar C; Kreitman RJ; Yuan CM; Stetler-Stevenson M
    Am J Clin Pathol; 2011 Oct; 136(4):625-30. PubMed ID: 21917686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
    Matutes E; Morilla R; Owusu-Ankomah K; Houliham A; Meeus P; Catovsky D
    Leuk Lymphoma; 1994; 14 Suppl 1():57-61. PubMed ID: 7820054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5 positive hairy cell leukemia: A rare case report with brief review of literature.
    Jain D; Dorwal P; Gajendra S; Pande A; Mehra S; Sachdev R
    Cytometry B Clin Cytom; 2016 Sep; 90(5):467-72. PubMed ID: 27129891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of flow cytometry in the chronic lymphoid leukemias.
    DiGiuseppe JA; Borowitz MJ
    Semin Oncol; 1998 Feb; 25(1):6-10. PubMed ID: 9482521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Dual Immunohistochemistry Staining in Detection of Hairy Cell Leukemia in Bone Marrow.
    Gupta GK; Sun X; Yuan CM; Stetler-Stevenson M; Kreitman RJ; Maric I
    Am J Clin Pathol; 2020 Feb; 153(3):322-327. PubMed ID: 31665200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia.
    Robbins BA; Ellison DJ; Spinosa JC; Carey CA; Lukes RJ; Poppema S; Saven A; Piro LD
    Blood; 1993 Aug; 82(4):1277-87. PubMed ID: 7688993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A hairy B cell lymphoproliferative disorder resembling hairy cell leukemia].
    Yagi Y; Sakabe H; Kakinoki R; Yoshikawa K; Inoue T; Fujiyama Y; Machii T
    Rinsho Ketsueki; 2004 Apr; 45(4):312-5. PubMed ID: 15168448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD27-positive hairy cell leukemia-Japanese variant.
    Tabata R; Tabata C; Iwama H; Yasumizu R; Kojima M
    Virchows Arch; 2016 Mar; 468(3):375-9. PubMed ID: 26868143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics.
    Dong HY; Weisberger J; Liu Z; Tugulea S
    Am J Clin Pathol; 2009 Apr; 131(4):586-95. PubMed ID: 19289595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature.
    Gupta R; Yadav S; Mittal N; Rahman K; Sharma A; Gupta A; Nityan S
    J Cancer Res Ther; 2020; 16(1):120-126. PubMed ID: 32362621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.